Company Filing History:
Years Active: 2022
Title: André Laferrière: Innovator in Pharmaceutical Science
Introduction
André Laferrière is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments for pain management. His work exemplifies the intersection of research and practical application in medicine.
Latest Patents
Laferrière holds a patent for "Pharmaceutical salts/co-crystals of pentoxifylline, clonidine and linsidomine with caffeic, protocatechuic or alpha-lipoic acid and use thereof for treatment of pain." This patent discloses pharmaceutical salts and co-crystals that combine pentoxifylline, clonidine, and linsidomine with various acids. The method for preparing these compounds is also detailed, along with topical compositions that utilize these salts or co-crystals for effective pain treatment.
Career Highlights
André Laferrière is affiliated with the Royal Institution for the Advancement of Learning / McGill University, where he contributes to advancing pharmaceutical research. His work has garnered attention for its potential impact on pain management therapies.
Collaborations
Laferrière has collaborated with esteemed colleagues, including Terence J. Coderre and Oli Abate Fulas, who have also made significant contributions to the field of pain research. Their combined expertise enhances the quality and scope of their research endeavors.
Conclusion
André Laferrière's innovative work in pharmaceutical science highlights the importance of research in developing effective treatments for pain. His contributions continue to influence the field and pave the way for future advancements.